Market Overview

A Look At Benzinga Pro's Most-Searched Tickers For August 21, 2019


This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform.

  1. iBio (NYSE: IBIO) shares were down 14% to $0.76 after rising more than 200% Tuesday after the company reported an agreement with United Therapeutics to produce recombinant human collagen-based bioink for 3D bioprinted organ transplants.
  2. Cemtrex (NASDAQ: CETX) shares were down 6% to $1.85. The company reported Q3 sales of $22.45 million up from $19.16 million year-over-year.
  3. Nabriva Therapeutics (NASDAQ: NBRV) shares were down 5.8% to $2.10. On Monday evening, the FDA approved its NDA for the oral and intravenous formulations of Xenleta, or lefamulin.
  4. Beyond Meat (NASDAQ: BYND) shares were up 0.7% to $155.10.
  5. Baidu (NASDAQ: BIDU) shares were down 0.6% to $108.05 after Nomura reiterated a Neutral rating on the stock and lowered the price target from $134 to $118.
  6. Home Depot (NYSE: HD) shares were up 1.1% to $219.46. Baird reiterated an Outperform rating on the stock.
  7. Sea Ltd (NYSE: SE) shares were down 1.6% to $32.47. The company reported Q2 worse-than-expected Q2 EPS results.
  8. Kohl’s (NYSE: KSS) shares were up 4.4% to $46.88.
  9. Jaguar Health (NASDAQ: JAGX) shares were up 7.8% to $1.24.
  10. VIVUS (NASDAQ: VVUS) shares were up 1.2% to $3.97. On Tuesday morning, the company reported new pilot clinical study results showing the addition of Qsymia significantly improved weight loss compared to surgery alone.

Related Articles (BIDU + BYND)

View Comments and Join the Discussion!

Posted-In: News Crowdsourcing Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at